Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

60.67

+0.26 (0.43%)

as of Jul 22, 2026, 8:00:00 pm Market Open.

1632 watching

Investor Insights

Jul 22, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has garnered a mostly positive outlook among various experts, highlighting its competitive positioning within the Canadian financial sector, particularly in comparison to major banks like TD and SLF. Analysts note MFC's ongoing strength in wealth management and healthy growth prospects in Asia, although there are concerns regarding its current valuation, as it trades over 2x book value and exhibits only moderate earnings growth. Despite being classified as slightly overbought, its charts remain healthy, with many recommending caution yet seeing potential for growth in the long run. The company's strong dividend yield and management strategies, particularly in alternative investments, also contribute to a favorable long-term investment story, although short-term volatility may present opportunities for those willing to enter at lower price points.

Consensus

Positive

Valuation

Fair Value

Similar

SLF,SLF

BUY

All insurers have suffered from the flat yield curve. Bond yields picking up is bullish for all financials. It's been in the penalty box since the financial crisis and a few stumbles. Getting paid to wait. Good risk/reward. Has to prove that it can deliver and execute as SLF does.

BUY

Really likes it. Not expensive multiple. Likes the Asian franchise. Asset management has done well. Hurt by low interest rates. Stable.

HOLD

Last quarter was disappointing. Great expansion into Asia. Recent drop in yields has hurt all the financials. Dividend yield, growth, safety. Not everything in your portfolio fires at the same time. Some things you just tuck away and wait. Good company, growing. Yield is 4-5%, better than cash or bonds.

PAST TOP PICK

(A Top Pick Jul 17/20, Up 34%) There is no reason to sell it. The shares remain cheap and offer an excellent yield. They offer good upside potential.

HOLD

Massive investment in Asia is one of the positives. Long-term opportunity is good. Interest rate sensitivity of the lifecos can have a magnified effect the stock price. As a long-term investor, don't worry about this.

TOP PICK

Goes back to the caution on broader market. Has not seen a big run like other stocks. Yields over 4% at current levels and could increase it. Continued growth trends. Collect your dividend while you are in a stable entity and wait for upside. Good for when things look frothy. (Analysts’ price target is $29.02)

PAST TOP PICK

(A Top Pick Jun 05/20, Up 31%) They have had a great run. The company has underlying good things happening. Looking for better days.

HOLD

Likes it and a lot of the insurers. A good long-term name, though he owns SLF and GWO instead. Expects dividend to increase over time by 8-10% yearly. Pullback due to interest rates coming down. Rates will probably move higher 12-24 months out. Asia exposure is a growing segment. Yield is 4%.

HOLD

It is the most discounted insurance company in Canada. It is trading at this level because it has been the performance laggard for quite some time. It has become a show-me story. However if you were going to buy an insurance company, this would be the one to buy. There is the chance of a bounce back or a trading opportunity. It has a decent dividend while you wait for an uptick.

BUY ON WEAKNESS

Would hold and it is getting close to adding back to it. They are one of the biggest at risk plays of interest rates going down. They are geared to benefit from higher interest rates. Moves out of financials is hurting their stock price. Would add on weakness.

TOP PICK

Canada's largest lifeco. Geographically diversified. Asia is demographically advantaged. The US business is lagging, but they're working on this. Canadian business is steady-eddy. Investing relentlessly in tech. Stock is inexpensive. Yield is 4.44%. (Analysts’ price target is $28.83)

BUY

The most volatile of Canadian lifecos, because it has the greatest difference between reported earnings and core earnings due to having a ton of both market and interest rate exposure. Likes it. Nice franchise in the US and Asian exposure to the emerging consumer. It's done increasingly well the last 10 years.

BUY

Interesting, likes the name. Perhaps management doesn't pay out more to shareholders or buy back shares because they want to expand or keep cash on hand. Doing well. Will benefit long-term from growth in Asia. 7-8x forward earnings, with 7-9% earnings growth going forward. Revenues and earnings will grow. He owns SLF and GWO instead. Yield of 4.5%.

BUY

Banks or lifecos? She likes both sectors, so it's not an either-or question. Banks will benefit from the reopening/recovery. She expects earnings upside and revisions probably later this year. Bank stocks have had a nice rally this year, but long term they remain attractive given their yields. The lifecos' valuations remain good, and wealth management offers key growth. She likes MFC's presence in Asia for its strong long-term growth. She owns TD, Royal and BNS.

DON'T BUY

He does not own life insurance companies as they are the most commoditized form of insurance. The banks have done better than the insurance companies (11% vs. 5%) unless you are looking for a short term trade, he would favour a bank. (Analysts’ price target is $29.00)

Showing 241 to 255 of 2,283 entries

Most Recent Experts

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

CNBC

John Stephenson

Stephenson & Company Capital Management

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Julien Nono-Womdim

Goodreid Investment Council

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)